Biotechnology Value Fund, L.P. | Stock Discussion Forums

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
Biotechnology Value Fund, L.P.

An SI Board Since January 1998

Posts	SubjectMarks	Bans
4974	145	0

Emcee: scaram(o)uche	Type: Moderated

Introduction Compact

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Posted
4649	California college gets $16 million donation for stem cell center By Paul Elias	sim1	5/12/2006
4648	5/9/2006 NOVC Drug maker Novacea cuts proposed IPO price Novacea, a developer o	sjemmeri	5/9/2006
4647	Cyclacel Pharmaceuticals Announces $45 Million Private Placement Thursday April	nigel bates	4/27/2006
4646	4/26/2006 BMTI Biotechnology firm BioMimetic sets terms BioMimetic Therapeutics	sjemmeri	4/26/2006
4645	I don't know much about this Bio. Found this piece of Info. Biotech seeks $	dr.praveen	4/24/2006
4644	IPOs of Drug, Medical-Device Makers Drag the Overall Market [WSJ] By LYNN COWAN	Doc Bones	4/24/2006
4643	Discovery Labs Secures $50 Million Committed Equity Financing Facility Wednesday	nigel bates	4/19/2006
4642	On the programs that make it - absolutely. (That's what ticked me off about	nigel bates	4/19/2006
4641	As bio investors is a 27% compounded rate of return what we should be aiming for	rkrw	4/19/2006
4640	Dynavax to Advance Cancer, Hepatitis B and Hepatitis C Therapy Programs With $50	nigel bates	4/19/2006
4639	4/14/2006 NOVC Cancer treatment firm Novacea sets IPO terms Novacea, a biopharm	sjemmeri	4/17/2006
4638	Greenspan pans Sarbanes (& gores Oxley ??) - news.ft.com - for losing the	nigel bates	4/13/2006
4637	wsj: IPOs of Two Drug Companies Drop as Investors Balk at Risk By LYNN COWAN Ap	mopgcw	4/13/2006
4636	forbes: Soros-Backed Replidyne Registers For IPO Chris Noon, 04.06.06, 5:42 PM E	mopgcw	4/13/2006
4635	Forbes: Biotech's Financial Lifeline Kerry A. Dolan, 04.10.06, 6:00 AM ET S	mopgcw	4/13/2006
4634	Gilead Invests $25 Million in Corus Pharma Wednesday April 12, 4:00 pm ET Establ	dr.praveen	4/13/2006
4633	4/12/2006 VNDA Drug developer Vanda Pharmaceuticals prices at $10 Vanda Pharmac	sjemmeri	4/12/2006
4632	The Perlegen thread is here for those interested Subject 56256	Mike McFarland	4/10/2006
4631	4/10/2006 PERL Biotech Perlegen Sciences files for IPO Perlegen Sciences, a bio	sjemmeri	4/10/2006
4630	Renovo Announces Offer Price of 87 pence per Share <pre>7 April, 2006 - R	nigel bates	4/7/2006
4629	4/5/2006 RDYN Biotech Replidyne files for IPO Replidyne, a biopharmaceutical co	sjemmeri	4/6/2006
4628	4/4/2006 QTRX Drug developer Quatrx sets terms Quatrx Pharmaceuticals, a develo	sjemmeri	4/5/2006
4627	Visicu prices above range for debut By Steve Gelsi, MarketWatch Last Update: 8:1	dr.praveen	4/5/2006
4626	Message 22324868 No rush to my Q..esp. since it's an A-B-C one for this gro	zeta1961	4/4/2006
4625	A bit OT but as a follow-up, EICU upped the range and it could have a bit of pop	sjemmeri	4/4/2006

Go to reply# or date (mm/dd/yy):